John Ransom
Stock Analyst at Raymond James
(4.60)
# 176
Out of 5,182 analysts
208
Total ratings
65.79%
Success rate
15.88%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Upgrades: Outperform | $330 | $370.75 | -10.99% | 14 | Apr 1, 2026 | |
| LMRI Lumexa Imaging Holdings | Upgrades: Strong Buy | $23 | $10.19 | +125.71% | 2 | Feb 9, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $27.69 | +8.36% | 10 | Oct 3, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $58.26 | +28.73% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $6.63 | +35.75% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $78.66 | +14.42% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $185.35 | +7.90% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $279.35 | +37.82% | 18 | May 5, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $427.18 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.85 | - | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $10 | $2.50 | +300.00% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $106.64 | -10.92% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $237.96 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $18.57 | +7.70% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $9.67 | +210.24% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $19.26 | -37.69% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $82.01 | +3.65% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $100.12 | +4.87% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $3.44 | +190.70% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.57 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.36 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $21.25 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $154.08 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.20 | - | 2 | Aug 9, 2017 |
UnitedHealth Group
Apr 1, 2026
Upgrades: Outperform
Price Target: $330
Current: $370.75
Upside: -10.99%
Lumexa Imaging Holdings
Feb 9, 2026
Upgrades: Strong Buy
Price Target: $23
Current: $10.19
Upside: +125.71%
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $27.69
Upside: +8.36%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $58.26
Upside: +28.73%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $6.63
Upside: +35.75%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $78.66
Upside: +14.42%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $185.35
Upside: +7.90%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $279.35
Upside: +37.82%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $427.18
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.85
Upside: -
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $2.50
Upside: +300.00%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $106.64
Upside: -10.92%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $237.96
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $18.57
Upside: +7.70%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $9.67
Upside: +210.24%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $19.26
Upside: -37.69%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $82.01
Upside: +3.65%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $100.12
Upside: +4.87%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $3.44
Upside: +190.70%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.57
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $26.36
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $21.25
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $154.08
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $14.20
Upside: -